Disease X/Virus X: AI-Driven Pathogen Mapping and Multi-Platform Vaccine Design, Strategic Blueprint for Combating Prophylaxis in India & Global, Therapeutic Interventions Against 3D Hypothetical Pathogen X

Authors

  • Yash Srivastav D.K.R.R Pharmacy College, Amberpur, Sitapur (Uttar Pradesh), India. 261303 Author
  • Shivani Singh D.K.R.R Pharmacy College, Amberpur, Sitapur (Uttar Pradesh), India. 261303 Author
  • Vivek Kumar D.K.R.R Pharmacy College, Amberpur, Sitapur (Uttar Pradesh), India. 261303 Author
  • Stuti Verma Aryakul College of Pharmacy and Research, Sitapur, Uttar Pradesh, India. 261303 Author
  • Kamini Prajapati D.K.R.R Pharmacy College, Amberpur, Sitapur (Uttar Pradesh), India. 261303 Author
  • Amita Singh D.K.R.R Pharmacy College, Amberpur, Sitapur (Uttar Pradesh), India. 261303 Author
  • Anup Kumar Sirbaiya K. P Singh Memorial Institute of Pharmacy, Sitapur, Lucknow, 261207 Author

DOI:

https://doi.org/10.64062/
Search on Google Scholar

Keywords:

  • Artificial Intelligence; Disease X; Genomic Surveillance; Precision Medicine; mRNA Vaccines; Viral Vector Vaccines; Pandemic Preparedness; Infectious Disease Management

Abstract

The rise in the prevalence of infectious diseases and the likelihood of more pandemics in the future calls for an increased need for innovative and effective preparedness solutions and rapid response technologies in healthcare. Disease X refers to an entirely novel pathogen that may trigger global health crises, economic and social disruptions, and healthcare system failure. This review discusses how AI technology can be used to map pathogens, conduct genomic surveillance, deliver precision medicine, and develop vaccine platforms in the context of addressing hypothetical infectious diseases like Disease X. Clinical evidence from human pandemics, such as COVID-19, Ebola, and Nipah, highlights the significance of mRNA vaccines, viral vector vaccines, and tailored treatment approaches in mitigating severity and mortality. Additionally, this review examines the impact of human immunological variability, socio-economic inequality, medical disparity, and inadequate digital frameworks on pandemic management, especially in developing nations such as India. Future possibilities include the development of novel technologies such as precision medicine utilizing AI, real-time genomics, nanoparticle-based medicines, biosensing devices, and CRISPR antivirals, among others. The implications from this literature indicate that the integration of technologies, such as AI and vaccine technology, in conjunction with an efficient public health framework is critical for increasing global preparedness to potential pandemics, such as those caused by Disease X.

References

as

Downloads

Published

2026-06-04

How to Cite

Srivastav, Y. S., Singh, S. S., Kumar, V. K., Verma, S. V., Prajapati, K. P., Singh, A. S., & Sirbaiya, A. K. S. (2026). Disease X/Virus X: AI-Driven Pathogen Mapping and Multi-Platform Vaccine Design, Strategic Blueprint for Combating Prophylaxis in India & Global, Therapeutic Interventions Against 3D Hypothetical Pathogen X. Journal of Pharmacology, Genetics and Molecular Biology, 2(3), 87-101. https://doi.org/10.64062/